Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer
about
sameAs
Acetylation-dependent regulation of Skp2 functionShp-1 mediates the antiproliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial cellsC-terminal phosphorylation controls the stability and function of p27kip114-3-3 suppresses the nuclear localization of threonine 157-phosphorylated p27(Kip1)A NIK-IKKα module expands ErbB2-induced tumor-initiating cells by stimulating nuclear export of p27/Kip1Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destructionFoxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressorPHLiPPing the switch on Akt and protein kinase C signalingRSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility.Knockin of mutant PIK3CA activates multiple oncogenic pathwaysAKT/PKB signaling: navigating downstreamPten dose dictates cancer progression in the prostateTransforming growth factor-beta induces Cdk2 relocalization to the cytoplasm coincident with dephosphorylation of retinoblastoma tumor suppressor proteinp27KIP1 phosphorylation by PKB/Akt leads to poor breast cancer prognosisDeregulation of p27 by oncogenic signaling and its prognostic significance in breast cancerStructure of HER receptors and intracellular localisation of downstream effector elements gives insight into mechanism of tumour growth promotionAutophagy and Apoptotic Crosstalk: Mechanism of Therapeutic Resistance in HER2-Positive Breast CancerNodal signaling promotes a tumorigenic phenotype in human breast cancerAkt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumabMislocalization of p27 to the cytoplasm of breast cancer cells confers resistance to anti-HER2 targeted therapyArgBP2gamma interacts with Akt and p21-activated kinase-1 and promotes cell survivalTumor suppressor ARF inhibits HER-2/neu-mediated oncogenic growthp27 suppresses cyclooxygenase-2 expression by inhibiting p38β and p38δ-mediated CREB phosphorylation upon arsenite exposureXB130: A novel adaptor protein in cancer signal transductionTumor suppressors and cell-cycle proteins in lung cancerCDK4 is an essential insulin effector in adipocytesActivation of the insulin-like growth factor-1 receptor alters p27 regulation by the epidermal growth factor receptor in oral squamous carcinoma cellsIdentification of WNK1 as a substrate of Akt/protein kinase B and a negative regulator of insulin-stimulated mitogenesis in 3T3-L1 cells.Inhibitory effect of ubiquitin-proteasome pathway on proliferation of esophageal carcinoma cells.p27Kip1 localization depends on the tumor suppressor protein tuberin.Glutamine deprivation induces abortive s-phase rescued by deoxyribonucleotides in k-ras transformed fibroblasts.Towards a systems biology approach to mammalian cell cycle: modeling the entrance into S phase of quiescent fibroblasts after serum stimulation.Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathwayCausal reasoning identifies mechanisms of sensitivity for a novel AKT kinase inhibitor, GSK690693.Loss of p27kip1 increases genomic instability and induces radio-resistance in luminal breast cancer cells.Simvastatin induces derepression of PTEN expression via NFkappaB to inhibit breast cancer cell growth.Upstream molecular signaling pathways of p27(Kip1) expression: effects of 4-hydroxytamoxifen, dexamethasone, and retinoic acids.Inhibition of PI-3K restores nuclear p27Kip1 expression in a mouse model of Kras-driven lung cancer.Fish oil targets PTEN to regulate NFkappaB for downregulation of anti-apoptotic genes in breast tumor growth.Chemical genetics approach to restoring p27Kip1 reveals novel compounds with antiproliferative activity in prostate cancer cells
P2860
Q24292805-EC7E22D0-E157-4EF3-8DD0-546F86FBA00AQ24297942-88E5233D-8F6C-47BF-AF3F-C1BF11AEFF72Q24307810-81165F24-0BFB-4075-ABC2-D72FE06CA214Q24322935-D9AA095E-6F44-4942-B065-8441DD6F3F37Q24338768-6D9A3FFB-4736-4038-8EAF-C17C2CED6846Q24602385-73637EAD-5F6F-47C6-8A17-EEB5626556F4Q24624817-168CCB3D-2F31-40B1-BC87-D07FAB249E68Q24625894-4498C169-37A0-4293-A657-F21C4E9E46B7Q24647282-A525FB4D-F948-4C4A-8EA9-562D00F41687Q24657412-E0C83766-6C63-4AAC-A9AB-1AC09AB536C8Q24657857-029BDE64-C804-4AE2-A55E-EB4968523F9BQ24791909-E662525D-B63B-4C63-AFE3-93DC3F5A08E6Q24794459-40AB8A6A-B636-44FB-B672-B9A2EFE975B2Q24803633-6990F094-3CAF-403A-BAF2-FFF5374B2C61Q24803723-DF525BDA-3AAF-4F4C-8F0C-C34D66117CECQ24803941-A6A0783B-EBF4-48DF-9B63-5CA930A5F11FQ26753162-EA24F39A-AD7D-479A-A606-94A448D7FDE9Q26826854-BA6FFCC5-4CF2-4A96-805E-00760C6123F1Q27851864-BD9EBB67-9F29-4CAD-B927-B41F830C8C90Q27853119-8C4ADEE1-01A0-47CF-9608-B1B55A0D7D6BQ28241283-69188489-46CA-4CAC-B43C-018A14E1C9F4Q28273757-71FDBF32-AABF-410E-9CC7-A296EE178A13Q28384606-8795BD82-AD34-4EEB-94F7-4B8E453EDC7BQ28388581-82FF911F-F9CE-4AF4-A461-78106C605E50Q28392478-CBC1CEAF-2EAA-4352-A886-999B956BC346Q28585816-107368F1-D0D6-4A90-8E20-F22C3E1C62A6Q30414074-43BE3E37-8CE3-4507-90B1-C836AFC892F0Q30781595-2C7D8C94-A89E-4DC6-9AA3-3880A7377F2FQ30837837-0CEB4EE5-E777-4A2A-B68F-DB5D8E54AAE0Q33292354-7FE855EC-8DAD-4CD5-810A-E12821AF0519Q33415058-15F0099A-BAAB-45A3-A835-C877434FE6B9Q33510472-34D666B8-695F-4F85-81FC-1B6F72BB7724Q33589182-9E69CB86-CF2D-4B1A-A822-83DD2054B53AQ33626022-B4CCCA19-70D7-4A2E-A064-8024D12B6C94Q33677415-57A3693A-F790-4846-B084-54CEA1EBBD1FQ33678607-F2F9D1C2-BD49-4FF1-8AE7-5CD8601ECD23Q33737205-9545053A-16A0-46C0-99D4-4E34BFFE54B4Q33740876-5CE4CE7D-0406-459D-9253-9C635B4B8EFDQ33761221-DE911CDE-821D-4674-AEC2-91938097E3F5Q33779578-B1F7E4A6-07F1-49E5-841B-0422A613F4D3
P2860
Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cytoplasmic relocalization and ...... osphorylation in breast cancer
@ast
Cytoplasmic relocalization and ...... osphorylation in breast cancer
@en
Cytoplasmic relocalization and ...... osphorylation in breast cancer
@nl
type
label
Cytoplasmic relocalization and ...... osphorylation in breast cancer
@ast
Cytoplasmic relocalization and ...... osphorylation in breast cancer
@en
Cytoplasmic relocalization and ...... osphorylation in breast cancer
@nl
prefLabel
Cytoplasmic relocalization and ...... osphorylation in breast cancer
@ast
Cytoplasmic relocalization and ...... osphorylation in breast cancer
@en
Cytoplasmic relocalization and ...... osphorylation in breast cancer
@nl
P2093
P2860
P3181
P356
P1433
P1476
Cytoplasmic relocalization and ...... osphorylation in breast cancer
@en
P2093
Alfonso Bellacosa
Amelia D'Alessio
Daniela Califano
Floriana Vinci
Gennaro Chiappetta
Giuseppe Viglietto
Maria Letizia Motti
Massimo Santoro
Paola Bruni
Philip Tsichlis
P2860
P2888
P304
P3181
P356
10.1038/NM762
P407
P577
2002-10-01T00:00:00Z
P5875
P6179
1031213076